loadpatents
Patent applications and USPTO patent grants for INTAS PHARMACEUTICALS LTD..The latest application filed is for "pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate".
Patent | Date |
---|---|
Non-pulsatile prolonged-release betahistine oral solid compositions Grant 11,433,058 - Patel , et al. September 6, 2 | 2022-09-06 |
Naltrexone Formulation App 20220273645 - PATEL; Alkeshkumar Narayanbhai ;   et al. | 2022-09-01 |
Pharmaceutical Composition Comprising Hmg-coa Reductase Inhibitors And Fenofibrate App 20220273652 - RAHANGDALE; Hitendra Netlal ;   et al. | 2022-09-01 |
Pharmaceutical Composition Of Temozolomide App 20220273646 - DESAI; Jwalant Vijaybhai ;   et al. | 2022-09-01 |
Stable Oral Composition Of Cyclophosphamide App 20220265688 - NAIDU; Venkataramana ;   et al. | 2022-08-25 |
Pharmaceutical Composition Of Imatinib App 20220265653 - DESAI; Jwalant Vijaybhai ;   et al. | 2022-08-25 |
Stable Formulation Of Cetrorelix App 20220233631 - GEORGE; Alex K ;   et al. | 2022-07-28 |
Essentially Sodium-free Effervescent Solid Pharmaceutical Compositions App 20220226368 - SUNE NEGRE; Jose Maria ;   et al. | 2022-07-21 |
Stable, Ready To Use Aqueous Pharmaceutical Composition Of Pemetrexed App 20220211709 - NAYANI; Anil ;   et al. | 2022-07-07 |
Process For Preparation Of Tofacitinib And Pharmaceutically Acceptable Salt Thereof App 20220153743 - SHANKAR; Rama ;   et al. | 2022-05-19 |
A Process For Preparation Of A Stable Pharmaceutical Composition Of Bortezomib App 20210393656 - MAHESHWARI; Kirti ;   et al. | 2021-12-23 |
Non-pulsatile Prolonged-release Betahistine Oral Solid Compositions App 20210161871 - PATEL; Himanshukumar Dasharathlal ;   et al. | 2021-06-03 |
Pharmaceutical Composition Of Nintedanib Esylate App 20210137917 - TELI; Nilesh Bhagwat ;   et al. | 2021-05-13 |
Stable Lyophilized Composition Of Cyclophosphamide App 20210100821 - PATEL; Aditya ;   et al. | 2021-04-08 |
Lyophilized pharmaceutical composition of Fc-peptide fusion protein Grant 10,918,698 - Gadgil , et al. February 16, 2 | 2021-02-16 |
Liquid Pharmaceutical Composition Of Adalimumab App 20200405864 - GADGIL; Himanshu ;   et al. | 2020-12-31 |
Liquid pharmaceutical composition of adalimumab Grant 10,688,187 - Gadgil , et al. | 2020-06-23 |
Pharmaceutical Composition Of Everolimus App 20200093804 - ARDESHANA; Ravikumar Mahendrabhai ;   et al. | 2020-03-26 |
Extended Release Pharmaceutical Composition Of Clozapine App 20200054573 - SAXENA; Mayank ;   et al. | 2020-02-20 |
Extended Release Capecitabine Capsules App 20200054659 - SEHGAL; Ashish ;   et al. | 2020-02-20 |
Composition Comprising Immediate Release And Extended Release Capecitabine App 20190358253 - GANDHI; Kashyap ;   et al. | 2019-11-28 |
Process For Preparation Of Carmustine App 20190169116 - KAPKOTI; Gobind Singh ;   et al. | 2019-06-06 |
Tablet-in-tablet Pharmaceutical Composition Comprising Cyclophosphamide And Capecitabine App 20190142755 - PATEL; Priyank ;   et al. | 2019-05-16 |
Liquid pharmaceutical composition of conjugated erythropoietin Grant 10,052,361 - Chhatbar , et al. August 21, 2 | 2018-08-21 |
Pharmaceutical composition having improved content uniformity Grant 10,016,447 - Patel , et al. July 10, 2 | 2018-07-10 |
Cloning, expression and purification method for the preparation of ranibizumab Grant 9,914,770 - Shandilya , et al. March 13, 2 | 2018-03-13 |
Pharmaceutical Composition For The Treatment Of Obesity App 20180015042 - SEHGAL; Ashish ;   et al. | 2018-01-18 |
Pharmaceutical Composition Having Improved Content Uniformity App 20170304328 - PATEL; Priyank ;   et al. | 2017-10-26 |
Liquid Pharmaceutical Composition Of Conjugated Erythropoietin App 20170112901 - CHHATBAR; Chandresh ;   et al. | 2017-04-27 |
Lyophilized Pharmaceutical Composition Of Fc-peptide Fusion Protein App 20170112903 - GADGIL; Himanshu ;   et al. | 2017-04-27 |
Liquid Pharmaceutical Composition Of Adalimumab App 20170106090 - GADGIL; Himanshu ;   et al. | 2017-04-20 |
Stable Transdermal Testosterone Gel App 20160361321 - DADHANIYA; Dhaval ;   et al. | 2016-12-15 |
Stable tigecycline composition Grant 9,511,145 - Parikh , et al. December 6, 2 | 2016-12-06 |
Process for the preparation of cabazitaxel and its intermediates Grant 9,487,496 - Lourdusamy , et al. November 8, 2 | 2016-11-08 |
Cloning, Expression & Purification Method For The Preparation Of Ranibizumab App 20160289314 - SHANDILYA; Harish ;   et al. | 2016-10-06 |
Pharmaceutical Composition Comprising Capecitabine And Cyclophosphamide App 20160243034 - PATEL; Priyank ;   et al. | 2016-08-25 |
Process for the preparation of fulvestrant Grant 9,315,540 - Lourdusamy , et al. April 19, 2 | 2016-04-19 |
Process For The Preparation Of Cabazitaxel And Its Intermediates App 20150307468 - Lourdusamy; Mettilda ;   et al. | 2015-10-29 |
Process For The Preparation Of Fulvestrant App 20150291652 - Lourdusamy; Mettilda ;   et al. | 2015-10-15 |
Process For Preparation Of Phenolic Monoesters Of Hydroxymethyl Phenols App 20110282094 - DESAI; Sanjay Jagdish ;   et al. | 2011-11-17 |
O-desmethylvenlafaxine Succinate Polymorph & Process For Preparing Thereof App 20110184067 - Pandya; Ashesh Kamalnayan ;   et al. | 2011-07-28 |
Novel Dosage Form Of Paliperidone And Process For Preparing The Same App 20110177137 - Chauhan; Vijaysinh Vanvirsinh ;   et al. | 2011-07-21 |
Method Of Preparing O-desmethylvenlafaxine App 20110098506 - DHOTRE; Balaram Jivraj ;   et al. | 2011-04-28 |
Stable Oxaliplatin Composition For Parenteral Administration App 20100267824 - Sehgal; Ashish ;   et al. | 2010-10-21 |
Taxane Derivative Composition App 20090275647 - SEHGAL; Ashish ;   et al. | 2009-11-05 |
NCAGE Code | 0805Y | INTAS PHARMACEUTICALS LIMITED |
NCAGE Code | SBHF6 | INTAS PHARMACEUTICALS LIMITED |
CAGE Code | 0805Y | INTAS PHARMACEUTICALS LIMITED |
CAGE Code | SBHF6 | INTAS PHARMACEUTICALS LIMITED |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.